✦ LIBER ✦

Cetuximab-based Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: Experience From an Area in Which Betel Nut Chewing Is Popular

✍ Scribed by Peter Mu-Hsin Chang; Yao-Yu Hsieh; Ming-Huang Chen; Cheng-Hwai Tzeng; Pen-Yuan Chu; Shyue-Yih Chang; Po-Min Chen; Muh-Hwa Yang

Book ID: 118654126
Publisher: Elsevier Science
Year: 2010
Tongue: Chinese
Weight: 198 KB
Volume: 73
Category: Article
ISSN: 1726-4901
DOI: 10.1016/s1726-4901(10)70064-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab (CTX) Plus Platinum-Based Chem

Cetuximab (CTX) Plus Platinum-Based Chemotherapy (CT) in Recurrent and Metastatic Head-and-Neck Squamous Cell Carcinoma (HN SCC): Our Extreme Experience

✍ Costa, D.; Gouveia, E.; Mouta, J.; Winckler, P.; Esteves, S.; Sargento, I.; Ferr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Overview of the efficacy of cetuximab in

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies

✍ Jan. B. Vermorken; Roy S. Herbst; Xavier Leon; Nadia Amellal; Jose Baselga 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

## Abstract ## BACKGROUND. The epidermal growth factor receptor (EGFR) inhibitor cetuximab is active in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The activity of cetuximab was compared with that of commonly used treatments in this setting. ## METHODS. All

5501 ORAL Cetuximab plus platinum-based

5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME)

✍ Vermorken, J.B.; Hitt, R.; Geoffrois, L.; Erfan, J.; Kawecki, A.; Zabolotnyy, D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB